Literature DB >> 22354169

Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice.

Som G Nanjappa1, Erika Heninger, Marcel Wüthrich, Thomas Sullivan, Bruce Klein.   

Abstract

Individuals who are immunocompromised, including AIDS patients with few CD4(+) T cells, are at increased risk for opportunistic fungal infections. The incidence of such infections is increasing worldwide, meaning that the need for antifungal vaccines is increasing. Although CD4(+) T cells play a dominant role in resistance to many pathogenic fungal infections, we have previously shown that vaccination can induce protective antifungal CD8(+) T cell immunity in the absence of CD4(+) T cells. However, it has not been determined whether vaccine-induced antifungal CD8(+) T cell memory can be maintained in the absence of CD4(+) T cell help. Here, we have shown in a mouse model of vaccination against blastomycosis that antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cells without loss of numbers or function for at least 6 months and that the cells protect against infection. Using a system that enabled us to induce and track antigen-specific, antifungal CD8(+) T cells, we found that such cells were maintained for at least 5 months upon transfer into naive mice lacking both CD4(+) T cells and persistent fungal antigen. Additionally, fungal vaccination induced a profile of transcription factors functionally linked with persistent memory in CD8(+) T cells. Thus, unlike bacteria and viruses, fungi elicit long-term CD8(+) T cell memory that is maintained without CD4(+) T cell help or persistent antigen. This has implications for the development of novel antifungal vaccine strategies effective in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354169      PMCID: PMC3287218          DOI: 10.1172/JCI58762

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

Review 1.  The role of programming in memory T-cell development.

Authors:  David Masopust; Susan M Kaech; E John Wherry; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

Review 2.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

3.  Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast.

Authors:  Thomas D Sullivan; Peggy J Rooney; Bruce S Klein
Journal:  Eukaryot Cell       Date:  2002-12

4.  Electroporation of Agrobacterium tumefaciens.

Authors:  A den Dulk-Ras; P J Hooykaas
Journal:  Methods Mol Biol       Date:  1995

Review 5.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

6.  CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Authors:  Edith M Janssen; Nathalie M Droin; Edward E Lemmens; Michael J Pinkoski; Steven J Bensinger; Benjamin D Ehst; Thomas S Griffith; Douglas R Green; Stephen P Schoenberger
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

Review 7.  Homeostasis of naive and memory T cells.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection.

Authors:  Jacob E Kohlmeier; Tres Cookenham; Shannon C Miller; Alan D Roberts; Jan P Christensen; Allan R Thomsen; David L Woodland
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

9.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

10.  CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.

Authors:  Yusuke Nakanishi; Bao Lu; Craig Gerard; Akiko Iwasaki
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  26 in total

1.  Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection.

Authors:  Marcel Wüthrich; Vanessa LeBert; Kevin Galles; Jane Hu-Li; Shlomo Z Ben-Sasson; William E Paul; Bruce S Klein
Journal:  J Infect Dis       Date:  2013-06-20       Impact factor: 5.226

2.  Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.

Authors:  S Ruan; D R Samuelson; B Assouline; M Morre; J E Shellito
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

3.  Autocrine Type I IFN Signaling in Dendritic Cells Stimulated with Fungal β-Glucans or Lipopolysaccharide Promotes CD8 T Cell Activation.

Authors:  Nargess Hassanzadeh-Kiabi; Alberto Yáñez; Ivy Dang; Gislâine A Martins; David M Underhill; Helen S Goodridge
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

Review 4.  Dendritic cells in antifungal immunity and vaccine design.

Authors:  René M Roy; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

Review 5.  Immunity to fungi.

Authors:  Salomé LeibundGut-Landmann; Marcel Wüthrich; Tobias M Hohl
Journal:  Curr Opin Immunol       Date:  2012-05-19       Impact factor: 7.486

6.  CBLB Constrains Inactivated Vaccine-Induced CD8+ T Cell Responses and Immunity against Lethal Fungal Pneumonia.

Authors:  Som G Nanjappa; Srinivasu Mudalagiriyappa; J Scott Fites; M Suresh; Bruce S Klein
Journal:  J Immunol       Date:  2018-07-27       Impact factor: 5.422

Review 7.  Adaptive immunity to fungi.

Authors:  Akash Verma; Marcel Wüthrich; George Deepe; Bruce Klein
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 8.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

9.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

10.  Endemic mycoses in immunocompromised hosts.

Authors:  Trent R Malcolm; Peter V Chin-Hong
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.